Literature DB >> 32690046

Cognitive performance in children and adolescents at high-risk for obsessive-compulsive disorder.

Elisa Teixeira Bernardes1, Leonardo Cardoso Saraiva2, Marina de Marco E Souza2, Marcelo Queiroz Hoexter2, Priscila Chacon2, Guaraci Requena3, Euripedes Constantino Miguel2, Roseli Gedanke Shavitt2, Guilherme Vanoni Polanczyk2, Carolina Cappi2, Marcelo Camargo Batistuzzo2,4.   

Abstract

BACKGROUND: Cognitive performance has been studied in adults with obsessive-compulsive symptoms (OCS) and in adult relatives of patients with obsessive-compulsive disorder (OCD) Meanwhile, few studies have been conducted with children under the same conditions. This study compared the neurocognitive domains previously associated with dysfunction in OCD, especially visuoconstructive ability, visuospatial memory, executive functions, and intelligence, in children and adolescents at high risk (HR) for OCD (n = 18) and non-OCD controls (NOC) (n = 31).
METHODS: For the HR group, we considered the first-degree relatives of patients with OCD that present OCS, but do not meet diagnostic criteria for OCD. Psychiatric diagnosis was assessed by experienced clinicians using the Structured Clinical Interview for DSM-IV and OCS severity was measured by the Yale-Brown Obsessive-Compulsive Scale. Neurocognitive assessment was performed with a comprehensive neuropsychological battery. Performance on the cognitive domains was compared between groups using Multivariate Analysis of Variance, whereas performance on the neuropsychological variables was compared between groups using independent t-tests in a cognitive subdomain analysis.
RESULTS: The cognitive domain analysis revealed a trend towards significance for impairments in the motor and processing speed domain (p = 0.019; F = 3.12) in the HR group. Moreover, the cognitive subdomain analysis identified a statistically significant underperformance in spatial working memory in the HR group when compared to the NOC group (p = 0.005; t = - 2.94), and a trend towards significance for impairments in non-verbal memory and visuoconstructive tasks in the HR group.
CONCLUSIONS: Our results suggest impairments in spatial working memory and motor and processing speed in a non-clinical sample of HR participants. Considering the preliminary nature of our findings, further studies investigating these neurocognitive domains as potential predictors of pediatric OCD are warranted.

Entities:  

Keywords:  Cognitive functions; First degree relatives; High-risk; Neuropsychological assessment; Obsessive-compulsive disorder; Obsessive-compulsive symptoms

Mesh:

Year:  2020        PMID: 32690046      PMCID: PMC7370498          DOI: 10.1186/s12888-020-02751-5

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN: 1471-244X            Impact factor:   3.630


  78 in total

1.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

2.  The neuropsychology of adult obsessive-compulsive disorder: a meta-analysis.

Authors:  Amitai Abramovitch; Jonathan S Abramowitz; Andrew Mittelman
Journal:  Clin Psychol Rev       Date:  2013-09-29

3.  Research Review: Neuropsychological test performance in pediatric obsessive-compulsive disorder--a meta-analysis.

Authors:  Amitai Abramovitch; Jonathan S Abramowitz; Andrew Mittelman; Abigail Stark; Kesley Ramsey; Daniel A Geller
Journal:  J Child Psychol Psychiatry       Date:  2015-04-13       Impact factor: 8.982

4.  Cognitive deficits in obsessive-compulsive disorder on tests of frontal-striatal function.

Authors:  R Purcell; P Maruff; M Kyrios; C Pantelis
Journal:  Biol Psychiatry       Date:  1998-03-01       Impact factor: 13.382

5.  Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II).

Authors:  Jill Lobbestael; Maartje Leurgans; Arnoud Arntz
Journal:  Clin Psychol Psychother       Date:  2011 Jan-Feb

6.  Recall and recognition memory in obsessive-compulsive disorder.

Authors:  C R Savage; N J Keuthen; M A Jenike; H D Brown; L Baer; A D Kendrick; E C Miguel; S L Rauch; M S Albert
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1996       Impact factor: 2.198

7.  Subclinical obsessive-compulsive disorder in children and adolescents: additional results from a "high-risk" study.

Authors:  Donald W Black; Gary R Gaffney
Journal:  CNS Spectr       Date:  2008-09       Impact factor: 3.790

8.  Population-based, multigenerational family clustering study of obsessive-compulsive disorder.

Authors:  David Mataix-Cols; Marcus Boman; Benedetta Monzani; Christian Rück; Eva Serlachius; Niklas Långström; Paul Lichtenstein
Journal:  JAMA Psychiatry       Date:  2013-07       Impact factor: 21.596

9.  The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication.

Authors:  A M Ruscio; D J Stein; W T Chiu; R C Kessler
Journal:  Mol Psychiatry       Date:  2008-08-26       Impact factor: 15.992

10.  Intelligence quotient discrepancy indicates levels of motor competence in preschool children at risk for developmental delays.

Authors:  Tzu-Ying Yu; Kuan-Lin Chen; Willy Chou; Shu-Han Yang; Sheng-Chun Kung; Ya-Chen Lee; Li-Chen Tung
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-26       Impact factor: 2.570

View more
  2 in total

Review 1.  Neural Correlates of Executive Functioning in Anorexia Nervosa and Obsessive-Compulsive Disorder.

Authors:  Kai S Thomas; Rosalind E Birch; Catherine R G Jones; Ross E Vanderwert
Journal:  Front Hum Neurosci       Date:  2022-05-26       Impact factor: 3.473

2.  Word recognition memory and serum levels of Borna disease virus specific circulating immune complexes in obsessive-compulsive disorder.

Authors:  Yuanyuan Zhang; A Alwin Prem Anand; Liv Bode; Hanns Ludwig; Hinderk M Emrich; Detlef E Dietrich
Journal:  BMC Psychiatry       Date:  2022-09-08       Impact factor: 4.144

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.